SCHEMBL14930622

SCHEMBL14930622

C/C=C\N=c1\c2cc(OC)c(OC)cc2cc(-c2cc(OC)c(OC)c(-c3cc(-c4ccccc4)cc(-c4ccccc4)c3)c2)n1C

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CTDSP1 Q9GZU7 1/20 0.36
▸ FYN P06241 1/20 0.36
▸ NQO2 P16083 2/20 0.34
▸ L3MBTL1 Q9Y468 2/20 0.32
▸ ACHE P22303 1/20 0.32
▸ ACACA Q13085 1/20 0.32
▸ SMN1; SMN2 Q16637 2/20 0.32
▸ LMNA P02545 1/20 0.32
▸ PAX8 Q06710 1/20 0.32
▸ PDE1A P54750 1/20 0.31
▸ PDE1B Q01064 1/20 0.31
▸ PDE3B Q13370 1/20 0.31
▸ PDE1C Q14123 1/20 0.31
▸ PDE3A Q14432 1/20 0.31
▸ RET P07949 1/20 0.31
▸ RAB9A P51151 1/20 0.30
▸ ALDH1A1 P00352 3/20 0.30
▸ KDM4E B2RXH2 1/20 0.30
▸ HPGD P15428 1/20 0.30
▸ PDGFRB P09619 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12070662 0.73 PTAFR (0.51) CTDSP1FYNNQO2ACHEACACA
SCHEMBL12072009 0.69 CTDSP1 (0.46) CTDSP1FYNNQO2L3MBTL1ACHE
SCHEMBL12070664 0.68 NQO2 (0.42) CTDSP1FYNNQO2PDE1APDE1B
SCHEMBL16510622 0.68 CTDSP1 (0.37) CTDSP1FYNNQO2L3MBTL1ACACA
SCHEMBL14906941 0.67 SRD5A1 (0.36) ACHERET
SCHEMBL14927045 0.65 PTAFR (0.49) CTDSP1FYNACHESMN1; SMN2LMNA
SCHEMBL12075016 0.65 PDGFRB (0.73) FYNSMN1; SMN2ALDH1A1PDGFRBPDGFRA
SCHEMBL14930629 0.64 RAC1 (0.60) CTDSP1L3MBTL1ACACASMN1; SMN2LMNA
Methoxy Aucuparin SCHEMBL8420787 0.62 KDM4E (0.62) CTDSP1FYNL3MBTL1ACHESMN1; SMN2
SCHEMBL14906858 0.62 FYN (0.43) CTDSP1FYNACHEACACASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130116278-A1 ANTIMICROBIAL AGENTS RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY 2013-05-09 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130116278-A1 ANTIMICROBIAL AGENTS MRPL21, ARG1, RPP30 CTDSP1 3302/4885FYN 3983/4885NQO2 104/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback